Abstract
The topical calcineurin antagonist tacrolimus plays an important role in the treatment of different forms of eczema because of its favorable risk profile. In addition, different off-label indications have been clinically tested where tacrolimus ointment has achieved clinical improvement. This article discusses off-label treatment of vitiligo, seborrheic dermatitis, steroid rosacea, perioral dermatitis, rosacea and lichen sclerosus.
MeSH terms
-
Administration, Topical
-
Chronic Disease
-
Dermatologic Agents / administration & dosage
-
Dermatologic Agents / adverse effects
-
Drug-Related Side Effects and Adverse Reactions / etiology*
-
Drug-Related Side Effects and Adverse Reactions / prevention & control
-
Evidence-Based Medicine*
-
Humans
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / adverse effects
-
Off-Label Use*
-
Skin Diseases / drug therapy*
-
Tacrolimus / administration & dosage*
-
Tacrolimus / adverse effects*
-
Treatment Outcome
Substances
-
Dermatologic Agents
-
Immunosuppressive Agents
-
Tacrolimus